[ { "@graph" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#pubInfo" } ] } ], "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#Head" }, { "@graph" : [ { "@id" : "http://identifiers.org/drugbank/DB00875", "@type" : [ "https://w3id.org/biolink/vocab/Drug" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Flupentixol" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Drug" } ] }, { "@id" : "http://purl.obolibrary.org/obo/MONDO_0005618", "@type" : [ "https://w3id.org/biolink/vocab/Disease" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Anxiety disorder" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#association", "@type" : [ "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/MONDO_0005618" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "http://identifiers.org/drugbank/DB00875" } ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "First-generation antipsychotics (FGA) use was more than that of second-generation antipsychotics (SGA) use in patients with anxiety disorder through the 9-year period. Sulpiride and flupentixol were the two most common FGA in the treatment of anxiety disorder. Patients with specific anxiety disorder (post-traumatic stress disorder, panic disorder/agoraphobia, generalized anxiety disorder, and obsessive-compulsive disorder), female sex, younger age (age < 65 years), comorbidity with major depression or minor depression, antidepressants concurrent use, and visits to psychiatrists, medical centers and primary care were significantly more likely to take prescribed antipsychotics" } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source" : [ { "@id" : "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" } ], "https://w3id.org/biolink/vocab/has_population_context" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#context" } ], "https://w3id.org/biolink/vocab/publications" : [ { "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/31077503" } ], "https://w3id.org/biolink/vocab/relation" : [ { "@id" : "http://purl.obolibrary.org/obo/NCIT_C94303" } ] }, { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#context", "@type" : [ "https://w3id.org/biolink/vocab/Cohort" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Adults" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Cohort" } ] } ], "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#assertion", "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-7641-6446" } ] } ], "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ", "http://www.w3.org/ns/prov#generatedAtTime" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2022-09-16T11:51:01.512573" } ], "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-1501-1082" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ { "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "B/MqL1xjLnXAbqVYpXDaJZJBTqIX8rJwghk994HWcn+lQV+jjUiCU//POvk8Tu/stai0EnqjVNmxumwuBXqLtJNWc0KytX3YALPlnNIt+I/jgf7kR4kr9EYdeWyoQ+MtLVLBgTi1nRTkUJsHPd1QnowN/6OvyvcbCg7jEdrKqU4=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ" } ] }, { "@id" : "https://w3id.org/biolink/vocab/", "http://purl.org/pav/version" : [ { "@value" : "2.3.0" } ] } ], "@id" : "http://purl.org/np/RApOJ3vxzPWK98DZsWB5ErvOYmG7uJ6MFnurHz2Ai6BBQ#pubInfo" } ]